Fedyk ER[au] - Search Results

Year	Number of Results
1994	2
1996	3
1997	2
1999	1
2001	2
2003	1
2005	1
2006	1
2007	1
2008	1
2009	1
2010	1
2012	1
2013	1
2018	1
2019	1
2020	1
2021	1
2023	0

1

Regulation of IgE and cytokine production by cAMP: implications for extrinsic asthma.

Fedyk ER, Adawi A, Looney RJ, Phipps RP. Fedyk ER, et al. Clin Immunol Immunopathol. 1996 Nov;81(2):101-13. doi: 10.1006/clin.1996.0165. Clin Immunol Immunopathol. 1996. PMID: 8906740 Free article. Review.

2

Prostaglandin receptors of the EP2 and EP4 subtypes regulate B lymphocyte activation and differentiation to IgE-secreting cells.

Fedyk ER, Harris SG, Padilla J, Phipps RP. Fedyk ER, et al. Adv Exp Med Biol. 1997;433:153-7. doi: 10.1007/978-1-4899-1810-9_31. Adv Exp Med Biol. 1997. PMID: 9561124 Review. No abstract available.

3

PGE2 regulation of B lymphocytes and T helper 1 and T helper 2 cells: induction of inflammatory versus allergic responses.

Fedyk ER, Brown DM, Phipps RP. Fedyk ER, et al. Adv Exp Med Biol. 1997;407:237-42. doi: 10.1007/978-1-4899-1813-0_35. Adv Exp Med Biol. 1997. PMID: 9321958 Review. No abstract available.

4

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects.

Esfandiari E, Chen M, Smithson G, Blair D, Faessel H, Wagner J, Mclean L, Fedyk ER. Esfandiari E, et al. Among authors: fedyk er. Clin Transl Sci. 2021 May;14(3):820-828. doi: 10.1111/cts.12871. Epub 2021 Mar 2. Clin Transl Sci. 2021. PMID: 33650758 Free PMC article. Clinical Trial.

5

Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.

Fedyk ER, Zhao L, Koch A, Smithson G, Estevam J, Chen G, Lahu G, Roepcke S, Lin J, Mclean L. Fedyk ER, et al. Br J Clin Pharmacol. 2020 Jul;86(7):1314-1325. doi: 10.1111/bcp.14241. Epub 2020 Feb 22. Br J Clin Pharmacol. 2020. PMID: 32045493 Free PMC article. Clinical Trial.

6

Regulation of B cell tolerance and triggering by immune complexes.

Fedyk ER, Borrello MA, Brown DM, Phipps RP. Fedyk ER, et al. Chem Immunol. 1994;58:67-91. Chem Immunol. 1994. PMID: 8011159 Review. No abstract available.

7

Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing.

Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden TM, Springer TA. Fedyk ER, et al. J Immunol. 2001 May 1;166(9):5749-54. doi: 10.4049/jimmunol.166.9.5749. J Immunol. 2001. PMID: 11313418

8

Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).

Liu F, Gonzalo JA, Manning S, O'Connell LE, Fedyk ER, Burke KE, Elder AM, Pulido JC, Cao W, Tayber O, Qiu Y, Ghosh S, Ocain TD, Hodge MR, Suzuki-Yagawa Y. Liu F, et al. Among authors: fedyk er. Prostaglandins Other Lipid Mediat. 2005 May;76(1-4):133-47. doi: 10.1016/j.prostaglandins.2005.03.001. Prostaglandins Other Lipid Mediat. 2005. PMID: 15967168

9

A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys.

Korver W, Carsillo M, Yuan J, Idamakanti N, Wagoner M, Shi P, Xia CQ, Smithson G, McLean L, Zalevsky J, Fedyk ER. Korver W, et al. Among authors: fedyk er. J Pharmacol Exp Ther. 2019 Aug;370(2):182-196. doi: 10.1124/jpet.119.256602. Epub 2019 May 13. J Pharmacol Exp Ther. 2019. PMID: 31085699

10

Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.

Csizmadia V, Csizmadia E, Silverman L, Simpson C, Raczynski A, O'Brien L, Gallacher M, Cardoza K, Kadambi VJ, Fedyk ER, Alden CL. Csizmadia V, et al. Among authors: fedyk er. Vet Pathol. 2010 Mar;47(2):358-67. doi: 10.1177/0300985809358423. Epub 2010 Feb 1. Vet Pathol. 2010. PMID: 20124009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results